Late radiation effects to the rectum and bladder in gynecologic cancer patients:: The comparison of LENT/SOMA and RTOG/EORTC late-effects scoring systems

被引:46
作者
Anacak, Y [1 ]
Yalman, D [1 ]
Özsaran, Z [1 ]
Haydaroglu, A [1 ]
机构
[1] Ege Univ, Fac Med, Dept Radiat Oncol, TR-35100 Izmir, Turkey
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2001年 / 50卷 / 05期
关键词
LENT/SOMA; RTOG/EORTC; cervixuteri carcinoma; endometrium carcinoma; late radiation effects;
D O I
10.1016/S0360-3016(01)01527-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To test the correlation of LENT/SOMA and RTOG/EORTC late-effect scales for rectum and bladder, 116 cases with gynecologic malignancies that were treated with radiotherapy were assessed with both scales. Methods and Materials: All cases had been treated at least 6 months before the date of assessment with external beam radiotherapy (50-54 Gy to midline) and 1-2 fractions of HDR brachytherapy (2 x 8.5 Gy to point-A for 32 inoperable cases; 1 x 9.25 Gy to 5-9 mm from the ovoid surface for 84 postoperative cases). The patients were questioned with both scales, and the correlation between the two scales was analyzed by Spearman's rho (rank correlation) test. Results: There were 64 cases with uterine cervix carcinoma and 52 cases with endometrium carcinoma, The overall (external + brachy) doses to ICRU points were 57.8 +/- 3.8 Gy for rectum and 59.3 +/- 4.9 Gy for bladder. The statistical analysis of LENT/SOMA and RTOG/EORTC scales revealed a very good correlation for rectum (r = 0.81; p < 0.01) and a good correlation for bladder (r = 0.72; p < 0.01). Conclusion: The LENT/SOMA system is a further step on the reporting of late radiation effects. Some modifications will improve its precision, and multicentric randomized studies are needed to test its validity. (C) 2001 Elsevier Science Inc.
引用
收藏
页码:1107 / 1112
页数:6
相关论文
共 12 条
  • [1] [Anonymous], 1995, RADIOTHER ONCOL, V35, P17
  • [2] [Anonymous], 1995, INT J RAD ONCOL BIOL, V31, P1048
  • [3] Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 Gy) conformal radiotherapy for prostate cancer, using dose-volume histograms
    Boersma, LJ
    van den Brink, M
    Bruce, AM
    Shouman, T
    Gras, L
    te Velde, A
    Lebesque, JV
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 41 (01): : 83 - 92
  • [4] TOXICITY CRITERIA OF THE RADIATION-THERAPY ONCOLOGY GROUP (RTOG) AND THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER (EORTC)
    COX, JD
    STETZ, J
    PAJAK, TF
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 31 (05): : 1341 - 1346
  • [5] Correction for the use of the SOMA LENT tables
    Denekamp, J
    Bartelink, H
    Rubin, P
    [J]. RADIOTHERAPY AND ONCOLOGY, 1996, 39 (02) : 191 - 191
  • [6] Correction for the use of the SOMA LENT tables
    Denekamp, J
    Bartelink, H
    Rubin, P
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 35 (02): : 417 - 417
  • [7] Chronic rectal bleeding after high-dose conformal treatment of prostate cancer warrants modification of existing morbidity scales
    Hanlon, AL
    Schultheiss, TE
    Hunt, MA
    Movsas, B
    Peter, RS
    Hanks, GE
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 38 (01): : 59 - 63
  • [8] Carcinoma of the cervical stump: Retrospective analysis of 77 cases
    HannounLevi, JM
    Peiffert, D
    Hoffstetter, S
    Luporsi, E
    Bey, P
    Pernot, M
    [J]. RADIOTHERAPY AND ONCOLOGY, 1997, 43 (02) : 147 - 153
  • [9] LATE EFFECTS TOXICITY SCORING - THE SOMA SCALE
    PAVY, JJ
    DENEKAMP, J
    LETSCHERT, J
    LITTBRAND, B
    MORNEX, F
    BERNIER, J
    GONZALESGONZALES, D
    HORIOT, JC
    BOLLA, M
    BARTELINK, H
    [J]. RADIOTHERAPY AND ONCOLOGY, 1995, 35 (01) : 11 - 15
  • [10] Potter R, 2000, Cancer Radiother, V4, P159, DOI 10.1016/S1278-3218(00)88900-3